Explore the comprehensive report detailing 11+ companies and pipeline drugs. Key areas include drug profiles, clinical stages, and therapeutic assessments. Discover emerging therapeutics from major ...

Bain Capital bought Mitsubishi Tanabe Pharma for $3.5 billion while Blackstone acquired a majority stake in one of Japan’s ...

Japanese drugmaker Shionogi said on Wednesday that it will acquire Torii Pharmaceutical , a subsidiary of Japan Tobacco , for ...

Ascendis, Ascendis Pharma, the Ascendis Pharma logo, the company logo, TransCon, SKYTROFA ®, and YORVIPATH ® are trademarks owned by the Ascendis Pharma group.

COPENHAGEN, Denmark, May 01, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced financial results for the first quarter ended March 31, 2025, and provided a business update.

“This is the third agreement established by Araris, after the successful collaboration with Taiho Pharmaceutical announced in November 2023, and with Chugai Pharmaceutical Co., Ltd most recently ...

Ono Pharmaceutical Co., Ltd., one of the largest pharmaceutical companies in Japan, announced that it has entered into a basic agreement with Seikagaku Corporation related to co-development and ...

Aurora Pharmaceutical, however, is taking a different approach. Aurora Pharmaceutical logo Under the leadership of CEO Dr. Mike Strobel - a career veterinarian who grew up on a cattle farm - the ...

Mumbai: Suven Pharmaceuticals Limited, a contract development and manufacturing organization (CDMO), has announced that it has received final approval from the Department of Pharmaceuticals (DoP), ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME), ...

BERLIN, April 25, 2025--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of ...